Diabetic Neuropathie
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants were selected from a specialized outpatient service and regarded as suitable to participate in this study if they fulfilled the following criteria: clinical diagnoses of diabetic polyneuropathy; aged from 30 to 69 years; not lactating; no history of brain surgery, tumor, or intracranial metal implantation
Exclusion criteria
Exclusion criteria: Participants with any uncontrolled clinical disease, such as thyroid disease, cardiovascular, pulmonary, haematological or renal disease; alcohol or other substance abuse; pregnancy; lactation; neuropsychiatric disorders; history of epilepsy and metallic implants in the head were excluded; patients with significant cognitive dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain improvement in active M1 group, evaluated through the visual analogue scale for pain with an increase of 30% | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life improvement in active M1 group, verified through the SF-36 questionnaire, from the verification of a 30% increase;Functional capacity improvement in active M1 group, verified through the six minutes walking test, by increasing the distance that participant walked | — |
Countries
Brazil
Contacts
Universidade Federal do Rio Grande do Norte